Targeted Strategies for Today's Evolving Markets

MissionIR Blog

AdvanSource Biomaterials Corporation (ASB) Files Patent for Newly Launched ChronoSil Polymer Product

AdvanSource Biomaterials Corp., a leading developer and manufacturer of advanced polymer materials that provide critical characteristics in the design and development of medical devices, recently announced that the company has filed a patent for its newly launched ChronoSil polymer product, a silicone-urethane copolymer.

The company’s biomaterials are used in devices that are designed for treating a broad range of anatomical sites and disease states. The ChronoSil product family maintains the inherent benefits of a polycarbonate-based urethane combined with silicone’s industry-recognized advantages, including heightened elongation, superior elasticity and a low coefficient of friction.

“We were pleased to announce our new biomaterial product, ChronoSil, a thermoplastic silicone polycarbonate urethane, which was exhibited at the recent MEDTEC IRELAND Medical Design and Manufacturing Exhibition and Conference in Galway, Ireland,” stated Michael Adams, president and chief executive officer of AdvanSource Biomaterials Corporation.

”Two of the objectives that are key to our business strategy include the development of innovative biomaterials to meet the needs of medical device developers and manufacturers while building additional value through a growing portfolio of patented products.” Mr. Adams continued, “This recent patent application supports our commitment to both of these objectives. We are pleased with the efforts of our research and development team and look forward to continued innovation from this talented group of scientists and engineers.”

Let us hear your thoughts below:

This entry was posted in Small Cap News. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *